Results 1 to 10 of about 45,912 (262)

Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau. [PDF]

PLoS Neglected Tropical Diseases, 2012
BackgroundUse of cholera vaccines in response to epidemics (reactive vaccination) may provide an effective supplement to traditional control measures.
Andrew S Azman, Francisco J Luquero, Amabelia Rodrigues, Pedro Pablo Palma, Rebecca F Grais, Cunhate Na Banga, Bryan T Grenfell, Justin Lessler   +7 more
doaj   +18 more sources

An overview of VaxchoraTM, a live attenuated oral cholera vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2020
Cholera remains a public health threat among the least privileged populations and regions affected by conflicts and natural disasters. Together with Water, Sanitation and Hygiene practices, use of oral cholera vaccines (OCVs) is a key tool to prevent ...
Tarun Saluja, Vijayalaxmi V. Mogasale, Jean-Louis Excler, Jerome H. Kim, Vittal Mogasale   +4 more
doaj   +4 more sources

Controlling cholera in the Ouest Department of Haiti using oral vaccines. [PDF]

PLoS Neglected Tropical Diseases, 2017
Following the 2010 cholera outbreak in Haiti, a plan was initiated to provide massive improvements to the sanitation and drinking water infrastructure in order to eliminate cholera from the island of Hispaniola by 2023.
Alexander Kirpich, Thomas A Weppelmann, Yang Yang, John Glenn Morris, Ira M Longini   +4 more
doaj   +3 more sources

Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients [PDF]

Nature Communications, 2018
Post-diagnostic use of cholera vaccine can improve the prognosis in patients with colorectal cancer suggesting cholera toxin might have an antineoplastic effect.
Jianguang Ji, Jan Sundquist, Kristina Sundquist   +2 more
doaj   +2 more sources

An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India. [PDF]

PLoS Neglected Tropical Diseases, 2015
BACKGROUND:Service provider costs for vaccine delivery have been well documented; however, vaccine recipients' costs have drawn less attention. This research explores the private household out-of-pocket and opportunity costs incurred to receive free oral
Vittal Mogasale, Shantanu K Kar, Jong-Hoon Kim, Vijayalaxmi V Mogasale, Anna S Kerketta, Bikash Patnaik, Shyam Bandhu Rath, Mahesh K Puri, Young Ae You, Hemant K Khuntia, Brian Maskery, Thomas F Wierzba, Binod Sah   +12 more
doaj   +3 more sources

Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia [PDF]

BMJ Open, 2022
Introduction Zambia experienced a major cholera outbreak in 2017–2018, with more than 5905 cases reported countrywide, predominantly from the peri-urban slums of Lusaka city.
Victor M Mukonka, Modest Mulenga, C Michelo, Khozya Zyambo, Cephas Sialubanje, Muzala Kapina, Orbrie Chewe, Belem Blamwell Matapo, Albertina Moraes Ngomah, Brittany Gianetti, William Ngosa, Mpanga Kasonde, Kunda Musonda, Nyambe Sinyange, Patricia Bobo, Lucy Mazyanga, Nathan Bakyaita   +16 more
doaj   +2 more sources

Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries [PDF]

BMC Public Health
Background The global resurgence of cholera, a diarrhoeal disease, has resulted in vaccine demand that exceeds the currently available supply resulting in global calls for next generation cholera vaccines.
Dijana Spasenoska, Anna-Lea Kahn, Malika Bouhenia, Naveena Aloysia D’Cor, Jung-Seok Lee, Se Eun Park, Julia Lynch   +6 more
doaj   +2 more sources

Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis [PDF]

BMJ Global Health
Introduction Millions of Euvichol-Plus doses have been deployed from the global oral cholera vaccine stockpile in over 20 cholera-affected countries. However, information on Euvichol-Plus’s effectiveness is limited.
Amanda Tiffany, Ashraful Islam Khan, Firdausi Qadri, John D Clemens, Faisal Ahmmed, Farhana Khanam, Tahmina Shirin, Fahima Chowdhury, Md. Taufiqul Islam, Md Nazmul Islam, Md Nazmul Hasan Rajib, Md Ismail Hossen, Md. Taufiqur Rahman Bhuiyan, Shahinur Haque, Prasanta Kumar Biswas, Amirul Islam Bhuiyan, Zahid Hasan Khan, Mohammad Ashraful Amin, Aninda Rahman, S M Shahriar Rizvi, Lucy Breakwell   +20 more
doaj   +2 more sources

Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo [PDF]

Emerging Infectious Diseases
We conducted 4 years of epidemiologic and genomic surveillance of single-dose effectiveness of a killed whole-cell oral cholera vaccine (kOCV) and Vibrio cholerae transmission in the Democratic Republic of the Congo.
Christine Marie George, Alves Namunesha, Kelly Endres, Willy Felicien, Presence Sanvura, Jean-Claude Bisimwa, Jamie Perin, Justin Bengehya, Jean Claude Kulondwa, Ghislain Maheshe, Cirhuza Cikomola, Lucien Bisimwa, Alain Mwishingo, David A. Sack, Daryl Domman   +14 more
doaj   +2 more sources

A Metapopulation Model for Cholera with Variable Media Efficacy and Imperfect Vaccine

Journal of Mathematical Sciences and Modelling
In this paper, a metapopulation model has been developed and analysed to describe the transmission dynamics of cholera between two communities linked by migration, in the presence of an imperfect vaccine and a varying media awareness impact.
George Lawı, Phoebe Amadi, Job Bonyo
doaj   +2 more sources